| Objective:(FS-14)in patients with chronic fatigue syndrome of spleen-kidney-yang deficiency syndrome were studied by two different therapies,ie,Yishenduodu acupuncture(treatment group)and oral oryzanol tablets(control group),Self-Rating Depression Scale(SDS),Zung’s Self-Rating Anxiety Scale(SAS)and Pittsburgh Sleep Quality Index(PSQI),and evaluate the effect of tonifying the kidney Type of chronic fatigue syndrome,the clinical efficacy of the current clinical treatment of the disease innovative ideas,provide the basis.Method: The patients were divided into two groups according to the random number table,30 cases in the treatment group and the control group.Treatment group(Yishen regulation)law points: Yintang,Shen Ting,Baihui,Dazhui,the wind pool,Shenshu,too Creek,the sun;partial spleen Yang plus plus Neiguan,Zhongwan,Guan Yuan,Zusanli;Partial yin deficiency plus moxibustion Shenque,life door.The control group: to oral oryzanol tablets treatment.The treatment group was treated once every day for acupuncture and moxibustion,and the rats were treated for 6 weeks after continuous treatment for 6 weeks.After the end of treatment statistics of the observed indicators.The control group was set up for continuous administration of oryzanol tablets(manufactured by Guangdong Hengjian Pharmaceutical Co.,Ltd.).The specifications were as follows: 10 mg * 100 tablets and 2 TIDs.The patients were treated with oryzanol tablets continuously for 8 weeks.After the end of treatment statistics of the observed indicators.Results: Before treatment,there was no significant difference in gender,age,course of disease,PSQI,FS-14,SDS and SAS scores between the treatment group and the control group(P> 0.05).After 8 courses of treatment,the PSQI,FS-14,SDS and SAS scores of the two groups were statistically significant(P <0.05).Before and after the treatment group,(P <0.05).There was no significant difference between the SDS and the SAS in the control group(P <0.05),but there was no significant difference between the control group and the control group(P> 0.05),but there was no statistical difference(P> 0.05).There were no significant differences in sleep time and sleep disturbance between PSQI scores and sleep quality(P> 0.05),sleep quality,sleep duration,daytime dysfunction and PSQI scores(P <0.05).The total effective rate was 96% in the treatment group and 53% in the control group,the difference was statistically significant(P <0.05).Conclusions: The two treatments have a therapeutic effect on the treatment and improvement of chronic fatigue syndrome in the spleen and kidney yang,but the overall efficacy of the treatment group is significantly better than that of the control group,and all the scoring tables involved in the efficacy assessment,whether the score factor or The difference between the treatment group and the control group was significant(P <0.05),the difference was statistically significant. |
